BPG is committed to discovery and dissemination of knowledge
Case Control Study
Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Hepatol. Nov 27, 2026; 18(11): 123360
Published online Nov 27, 2026. doi: 10.4254/wjh.123360
Exploring the role of apolipoproteins in hepatitis B virus-related acute-on-chronic liver failure
Li-Min Cao, Lei Liu, Dao-Kuan Zhai, Bin Yang
Li-Min Cao, Dao-Kuan Zhai, Department of Science and Technology, The Third Central Hospital of Tianjin, Tianjin 300170, China
Li-Min Cao, Dao-Kuan Zhai, Department of Science and Technology, Tianjin Institute of Hepatobiliary Disease, Tianjin 300170, China
Li-Min Cao, Dao-Kuan Zhai, Department of Science and Technology, Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Tianjin 300070, China
Li-Min Cao, Department of Science and Technology, Nankai University Affiliated Third Center Hospital, Tianjin 300070, China
Lei Liu, Department of Gastroenterology and Hepatology, The Third Central Hospital of Tianjin, Tianjin 300170, China
Lei Liu, Department of Gastroenterology and Hepatology, Tianjin Institute of Hepatobiliary Disease, Tianjin 300170, China
Lei Liu, Department of Gastroenterology and Hepatology, Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Tianjin 300070, China
Bin Yang, Research Center, The Third Central Hospital of Tianjin, Tianjin 300170, China
Bin Yang, Research Center, Tianjin Institute of Hepatobiliary Disease, Tianjin 300170, China
Bin Yang, Research Center, Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Tianjin 300070, China
Author contributions: Cao LM and Yang B designed the research study, and conducted the analysis; Liu L and Zhai DK performed the research; Cao LM completed the manuscript and provided financial support; Liu L completed the manuscript revision.
AI contribution statement: The authors take full responsibility and accountability for all content of this manuscript, including any portions for which AI tools were used as assistive technologies. All AI-assisted outputs were carefully reviewed, validated, and approved by the authors. AI tools were not used to generate original scientific data, perform independent scientific analyses, or draw scientific conclusions.
Supported by Tianjin Health Research Project, No. TJWJ2022QN043; Science and Technology Support Project of Tianjin, No. 21ZXGWSY00040; Tianjin Natural Science Foundation Project, No. 23JCQNJC01830; and Beijing iGandan Foundation, No. iGandanF-1082024-RGG038.
Institutional review board statement: This study was approved by the Ethics Committee of the Tianjin Third Central Hospital (approval No. IRB2024-013-01). This clinical trial was registered at www.chictr.org.cn.
Informed consent statement: All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments. Residual blood samples from mandatory routine clinical tests were used in this study, and the institutional ethics committee approved a full waiver of informed consent due to the retrospective nature of the study and the minimal risk to participants.
Conflict-of-interest statement: On behalf of all authors, the corresponding author states that there is no conflict of interest.
STROBE statement: The authors have read the STROBE Statement-checklist of items, and the manuscript was prepared and revised according to the STROBE Statement-checklist of items.
Data sharing statement: The data that support the findings of this study are not openly available due to participant privacy protection requirements, and are stored in the controlled access data repository of Tianjin Third Central Hospital. Access can be applied for via formal institutional review procedures.
Corresponding author: Li-Min Cao, Assistant Professor, Department of Science and Technology, The Third Central Hospital of Tianjin, No. 83 Jintang Road, Hedong District, Tianjin 300170, China. rosemary1993@139.com
Received: May 18, 2026
Revised: August 3, 2026
Accepted: October 14, 2026
Published online: November 27, 2026
Processing time: 188 Days and 10.2 Hours
Core Tip

Core Tip: Identifying potential indicators for the prognosis of acute-on-chronic liver failure in patients treated with a plasma exchange-centered artificial liver support system holds great medical significance. Thus, supplementing the relevant proteins in serum samples using the most advanced proteomics technology represents an attractive future exploration direction.

Write to the Help Desk